Clinical trial
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients…
NCT00427570 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00427570 |
|---|---|
| Title | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery |
| Official title | A Clinical Trial to Evaluate Postoperative Immunotherapy and Postoperative Systemic Chemotherapy in the Management of Resectable Colon Cancer |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | BCG vaccine, biological therapy, fluorouracil, semustine, vincristine sulfate |
| Start date | Sep 1, 1977 |
| Completion | May 1, 2006 |
| First posted | Jan 29, 2007 |
| Last update posted | Jun 24, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: